Application no. and date | 14842538.2 (espacenet) (Federated) (European Patent Register), 20140905 | Patent/reg. no. and date | DK/EP 3042669, 20230308 | Publication date | 20160713 | Priority no. and date | JP 2013184684, 20130906 | EP pub. no. and date |
EP 3042669 20160713 | Effective date | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27 Kanda Nishiki-cho Chiyoda-ku, 1018444 Tokyo , JP | Applicant ref. no. | PU278939DKQ | Inventor | OKABE, Hiroyuki, c/o TAIHO PHARMACEUTICAL CO., LTD. 3 Okubo
Tsukuba-shi Ibaraki 300-2611, JP | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61K 31/513 (2006.01) , A61K 31/7072 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07K 16/22 (2006.01) , C07K 16/28 (2006.01) | Title | ANTITUMORMIDDEL OG FORSTÆRKER AF ANTITUMORVIRKNING | Int. application no. | JP2014073436 | Int. publication no. | WO2015034032 | Related patent (certificate) | CA 2024 00004 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|